新型口服抗凝剂(NOAC)简介

The Cardiology Pub Date : 2019-10-31 DOI:10.36478/TCARD.2014.7.10

R. Jayasinghe, R. Markham, Kais Hyasat, G. Adsett

{"title":"新型口服抗凝剂(NOAC)简介","authors":"R. Jayasinghe, R. Markham, Kais Hyasat, G. Adsett","doi":"10.36478/TCARD.2014.7.10","DOIUrl":null,"url":null,"abstract":"To produce a high quality article for physicians that reviews the current literature pertaining to NOAC's, in particular, their use in clinical practice, known drug interactions and side effect profile. Medline, Cochrane and PubMed databases were searched for the most recent and clinically sound articles pertaining apixaban, rivaroxaban and dabigatran. Researchers found the trials for each of these NOAC's to be sound and have results that can be translated into clinical practice.","PeriodicalId":22442,"journal":{"name":"The Cardiology","volume":"67 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Introduction to New Oral Anticoagulants (NOAC’s)\",\"authors\":\"R. Jayasinghe, R. Markham, Kais Hyasat, G. Adsett\",\"doi\":\"10.36478/TCARD.2014.7.10\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To produce a high quality article for physicians that reviews the current literature pertaining to NOAC's, in particular, their use in clinical practice, known drug interactions and side effect profile. Medline, Cochrane and PubMed databases were searched for the most recent and clinically sound articles pertaining apixaban, rivaroxaban and dabigatran. Researchers found the trials for each of these NOAC's to be sound and have results that can be translated into clinical practice.\",\"PeriodicalId\":22442,\"journal\":{\"name\":\"The Cardiology\",\"volume\":\"67 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36478/TCARD.2014.7.10\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36478/TCARD.2014.7.10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

为医生撰写一篇高质量的文章，回顾目前有关NOAC的文献，特别是它们在临床实践中的应用、已知的药物相互作用和副作用概况。Medline、Cochrane和PubMed数据库检索了有关阿哌沙班、利伐沙班和达比加群的最新和临床可靠的文章。研究人员发现，每一种NOAC的试验都是合理的，并且结果可以转化为临床实践。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Introduction to New Oral Anticoagulants (NOAC’s)

To produce a high quality article for physicians that reviews the current literature pertaining to NOAC's, in particular, their use in clinical practice, known drug interactions and side effect profile. Medline, Cochrane and PubMed databases were searched for the most recent and clinically sound articles pertaining apixaban, rivaroxaban and dabigatran. Researchers found the trials for each of these NOAC's to be sound and have results that can be translated into clinical practice.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Cardiology

自引率

0.00%

发文量